Cytokine-release syndrome: overview and nursing implications.
Cytokine-release syndrome is a symptom complex associated with the use of many monoclonal antibodies. Commonly referred to as an infusion reaction, it results from the release of cytokines from cells targeted by the antibody as well as immune effector cells recruited to the area. When cytokines are released into the circulation, systemic symptoms such as fever, nausea, chills, hypotension, tachycardia, asthenia, headache, rash, scratchy throat, and dyspnea can result. In most patients, the symptoms are mild to moderate in severity and are managed easily. However, some patients may experience severe, life-threatening reactions that result from massive release of cytokines. Severe reactions occur more commonly during the first infusion in patients with hematologic malignancies who have not received prior chemotherapy; severe reactions are marked by their rapid onset and the acuity of associated symptoms. Massive cytokine release is an oncologic emergency, and special precautions must be taken to prevent life-threatening complications. This article will present an overview of the etiology and management of cytokine-release syndrome in patients receiving monoclonal antibodies to better prepare oncology nurses to safely care for such patients.
Breslin
Sheila
S
Division of Oncology, Stanford University Medical Center Comprehensive Cancer Center, California, USA. sxb@stanford.edu
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D016207:Cytokines / Q000378:metabolism*; D019337:Hematologic Neoplasms / Q000451:nursing / Q000628:therapy*; D006801:Humans; D009859:Oncology Nursing
D000911:Antibodies, Monoclonal; D016207:Cytokines